ES8704881A1 - Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos. - Google Patents

Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos.

Info

Publication number
ES8704881A1
ES8704881A1 ES549853A ES549853A ES8704881A1 ES 8704881 A1 ES8704881 A1 ES 8704881A1 ES 549853 A ES549853 A ES 549853A ES 549853 A ES549853 A ES 549853A ES 8704881 A1 ES8704881 A1 ES 8704881A1
Authority
ES
Spain
Prior art keywords
group
yes
alkyl
aromatic hydrocarbon
arylacetic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES549853A
Other languages
English (en)
Other versions
ES549853A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of ES549853A0 publication Critical patent/ES549853A0/es
Publication of ES8704881A1 publication Critical patent/ES8704881A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE ANILIDAS DE ACIDOS ARILACETICOS SUSTITUIDOS. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), EN UN DISOLVENTE INERTE FRENTE A LA REACCION Y A TEMPERATURA ENTRE C50JC Y LA DE REFLUJO DEL SISTEMA REACCIONANTE, PARA OBTENER ANILIDAS DE ACIDOS ARILACETICOS SUSTITUIDOS DE FORMULA (I) DONDE AR ES UN GRUPO HETEROCICLICO O HIDROCARBILO AROMATICO, ALQUILO C 1 A 4, ALCOXI C 1 A 4 Y OTROS; X ES UN GRUPO HIDROXILO Y OTROS; R ES UN GRUPO HIDROCARBILO AROMATICO O HETEROCICLICO; Y N ES UN ENTERO DE 1 A 4. TIENEN APLICACIONES FARMACEUTICAS COMO ESTIMULANTES DEL METABOLISMO CEREBRAL.
ES549853A 1984-12-11 1985-12-11 Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos. Expired ES8704881A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59261197A JPS61140556A (ja) 1984-12-11 1984-12-11 新規なアリ−ル酢酸アニリド誘導体

Publications (2)

Publication Number Publication Date
ES549853A0 ES549853A0 (es) 1987-04-16
ES8704881A1 true ES8704881A1 (es) 1987-04-16

Family

ID=17358490

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549853A Expired ES8704881A1 (es) 1984-12-11 1985-12-11 Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos.

Country Status (4)

Country Link
EP (1) EP0184822A3 (es)
JP (1) JPS61140556A (es)
AU (1) AU5106585A (es)
ES (1) ES8704881A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8617653D0 (en) * 1986-07-18 1986-08-28 Ici Plc Amide derivatives
FR2730995B1 (fr) * 1995-02-23 1997-04-04 Cird Galderma Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US6444849B1 (en) * 1997-06-25 2002-09-03 Mitsubishi Chemical Corporation Amide derivatives
US6407120B1 (en) 1999-02-18 2002-06-18 Pfizer Inc. Neuropeptide Y antagonists
EP1033366A3 (en) * 1999-02-18 2000-12-27 Pfizer Products Inc. Amide derivatives useful as Neuropeptide Y (NPY) antagonists
DE10234057A1 (de) * 2002-07-26 2004-02-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB828695A (en) * 1955-03-10 1960-02-24 Farmaceutici Italia N-p-hydroxylphenyl amides with choleretic action

Also Published As

Publication number Publication date
AU5106585A (en) 1986-06-19
EP0184822A2 (en) 1986-06-18
ES549853A0 (es) 1987-04-16
JPS61140556A (ja) 1986-06-27
EP0184822A3 (en) 1987-12-09

Similar Documents

Publication Publication Date Title
ES8607277A1 (es) Acidos 7-amino-1-ciclopropil-6,8-dihalogeno-1,4-dihidro-4- oxo-3-quinolincarboxilico
AU536175B2 (en) (piperidinylalky) quinazoline derivatives
IE832405L (en) 1-phenyl-2-piperidinoalkanols.
AU3621689A (en) Carbamate compounds, compositions, and method of making the same
ES8801651A1 (es) Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isozazoles y furanos
AU591640B2 (en) Quinolonecarboxylic acid derivatives
EP0292979A3 (en) New alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
ES8704881A1 (es) Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos.
ES2010284A6 (es) Procedimiento para preparar derivados de tiourea.
AU4682985A (en) 2-(3,5-Dislkyl -4- Hydroxyphenyl) indole derivatives
ES8702390A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina
WO1991000729A3 (en) Bis-dioxopiperazines, and their use as protecting agents
ES8800255A1 (es) Procedimiento para preparar n6 -benzopirano- y benzotiopirano-adenosinas.
ES8201979A1 (es) Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano
ES8801648A1 (es) Procedimiento de preparar derivados bisimidazolinoamino, utiles como compuestos antialergicos.
AU4441593A (en) Tetrahydronaphthalene derivatives, their preparation and their application in therapy
ES8704463A1 (es) Procedimiento para preparar 2-(n-alquinil-n-fenilamino)-imidazolinas
ES8604096A1 (es) Procedimiento para la obtencion de derivados de acido feno- xifenilpropionico sustituidos
ES8602789A1 (es) Procedimiento para preparar derivados de 14-hidroxiimino- eburnano racemicos y opticamente activos
AU572147B2 (en) Dibenzopyran derivatives
AU4370489A (en) The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents